TRC041266
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TRC041266, covering 2022-12-27 to 2022-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of TRC041266 in Patients With Heart Failure, LVEF ≥40%, Diastolic Dysfunction and Type 2 Diabetes Mellitus [Phase 3]